Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Salivary Gland Neoplasms 1Rectal Neoplasms 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neoplasms 1Metastatic Malignant Female Reproductive System Neoplasm 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Breast Carcinoma In Situ 1Brain Neoplasms 1Astrocytoma 1Anatomic Stage II Breast Cancer AJCC v8 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Temozolomide 4abemaciclib 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2vorasidenib 1pembrolizumab 1Vorinostat 1Vincristine 1Specimen Handling 1Radiotherapy, Conformal 1Protons 1Proton Therapy 1Procarbazine 1OKN 007 1Nivolumab 1Magnetic Resonance Spectroscopy 1Lomustine 1Irinotecan 1DNA Methylation 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Biopsy 1BID protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Oligodendroglioma × Radiotherapy, Conformal × Clear all
NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
540 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡